<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.inveslogic.com">
<channel>
 <title>Blog Articles Tagged with &#039;clinical-trial&#039; at http://www.inveslogic.com</title>
 <link>http://www.inveslogic.com/tags/clinical-trial</link>
 <description>Blog Articles Tagged with &#039;clinical-trial&#039; at http://www.inveslogic.com</description>
 <language>en</language>
<item>
 <title>EMD Serono Snags US license for Tesamorelin From Theratechnologies</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1141734?rsstype=tag&amp;tag=clinical-trial</link>
 <description>   Theratechnologies and EMD Serono, US arm of Merck KGaA (MKGAY.PK), announced they have entered into a collaboration and licensing agreement for the exclusive commercialization rights to tesamorelin in the United States for the treatment of excess ...</description>
 <pubDate>Fri, 31 Oct 2008 06:44:29 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1141734?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>China Pharma Gets Green Light for Antibiotics Trial</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1141048?rsstype=tag&amp;tag=clinical-trial</link>
 <description>China Pharma Holdings (CPHI.OB) was given the go-ahead by the SFDA to begin clinical trials of a novel antibiotic combination formula. China Pharma describes the new product as a third generation Cephalosporin antibiotic combined with a bacterial-enz...</description>
 <pubDate>Thu, 30 Oct 2008 06:01:37 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1141048?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Biomarkers for Oral Cancer in Saliva</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-weblog/1130520?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Photo courtesy of iStockphoto, Bradley MasonResearchers have identified five protein biomarkers for oral squamous cell carcinoma, a form of oral cancer,found in the saliva. Researchers collected saliva samples from 64 patients with oral squamous cell...</description>
 <pubDate>Tue, 30 Sep 2008 10:58:28 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-weblog/1130520?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>3SBio Files for Approval of Anemia Treatment</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1127715?rsstype=tag&amp;tag=clinical-trial</link>
 <description>3SBio Inc. (SSRX) has filed for SFDA approval of a high-dose, 36,000 IU formulation of EPIAO for the treatment of anemia resulting from chemotherapy. Unlike 3SBio   s other formulations of EPO, this one would be exclusive to the company. A 36,000 IU ...</description>
 <pubDate>Fri, 26 Sep 2008 08:03:35 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1127715?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>China Biologic to Test New Plasma Product</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1124235?rsstype=tag&amp;tag=clinical-trial</link>
 <description>China Biologic Products, Inc. (CBPO.OB) received permission from the SFDA to begin a clinical trial of its new Human Coagulation Factor VIII product [FVIII], a coagulation treatment for hemophilia and mass hemorrhaging. China Biologic focuses on plas...</description>
 <pubDate>Thu, 18 Sep 2008 01:27:36 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1124235?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>China Biologic to Test New Plasma Product</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1124240?rsstype=tag&amp;tag=clinical-trial</link>
 <description>China Biologic Products, Inc. (CBPO.OB) received permission from the SFDA to begin a clinical trial of its new Human Coagulation Factor VIII product [FVIII], a coagulation treatment for hemophilia and mass hemorrhaging. China Biologic focuses on plas...</description>
 <pubDate>Thu, 18 Sep 2008 01:27:36 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1124240?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Commercializing biotechnology in China</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-blog/1124020?rsstype=tag&amp;tag=clinical-trial</link>
 <description>I recently had the opportunity to conduct a brief interview with Mireille Gingras, Ph.D. President and CEO of HUYA Bioscience on doing business with and in China:Tell me about HUYA and what makes the company unique?HUYA Bioscience International has p...</description>
 <pubDate>Wed, 17 Sep 2008 11:26:28 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-blog/1124020?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Gene Therapy for Chronic Pain Goes on Clinical Trial</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-weblog/1123468?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Scientists from the University of Michigan will begin a phase 1 clinical trial for the treatment of cancer-related painusing gene therapy: a novel gene transfer vector injected into the skin to deliver a pain-relieving gene to the nervous system.In t...</description>
 <pubDate>Tue, 16 Sep 2008 13:53:09 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-weblog/1123468?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Tianyin Wins Approval for Asthma Drug</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1121830?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Tianyin Pharmaceutical, Co. (TYNP.OB) will add to its list of modernized traditional Chinese medicines the recently SFDA-approved Laonian Kechuan Tablets, a new drug for the company which was approved with a dose of 0.25 gram/tablet. The product is a...</description>
 <pubDate>Fri, 12 Sep 2008 02:04:28 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1121830?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>A Delay and a Deal for Pfizer</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1120883?rsstype=tag&amp;tag=clinical-trial</link>
 <description>At the risk of getting more emails from conspiracy-theorist readers who think I report too much negative news about Pfizer (PFE), here comes another setback for the world&#039;s biggest drug company.Pfizer announced yesterday morning that it is pulling al...</description>
 <pubDate>Wed, 10 Sep 2008 04:24:53 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1120883?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1116566?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility.   Adefovir dipivoxil, the drug newly approved  for mar...</description>
 <pubDate>Fri, 29 Aug 2008 07:25:00 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1116566?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1116911?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility.   Adefovir dipivoxil, the drug newly approved  for mar...</description>
 <pubDate>Fri, 29 Aug 2008 07:25:00 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1116911?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Five Biopharma Companies Drop on Negative Drug News</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1116057?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower -- in the case of Amylin Pharmaceuticals (AMLN) and Cell Genesys (CEGE), much lower.After the closing bell Tuesday, Bristol-Myers Squibb (...</description>
 <pubDate>Thu, 28 Aug 2008 03:32:54 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1116057?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Xylitol May Prevent Early Childhood Tooth Decay</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-weblog/1114213?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Photo courtesy of iStockphoto, Craig Veltri In a recent clinical trial, researchers report a significant reduction of tooth decay in toddlers treated with the topical syrup xylitol, a naturally occurring non-cavity-causing sweetener.Researchers repor...</description>
 <pubDate>Tue, 19 Aug 2008 09:33:46 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-weblog/1114213?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Tabebuia impetiginosa Extract May Help Reduce Obesity, Diabetes and Heart Disease Risks</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-weblog/1113471?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Using rats as animal models, scientists have been able to demonstrate that extracts derived from the Central and South American-native plant Tabebuia impetiginosa (also known as Pink Ip   or Pink Lapacho) can block dietary fat absorption, and thus re...</description>
 <pubDate>Thu, 14 Aug 2008 13:03:41 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-weblog/1113471?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Abbott Laboratories: The Choice Within Big Pharma</title>
 <link>http://www.inveslogic.com/sectors/directory/etf-investor/1110296?rsstype=tag&amp;tag=clinical-trial</link>
 <description>So Big Pharma is hurting? Well, Standard &amp; Poor   s does estimate that patent expiration losses in 2008 will exceed $20 billion. I cannot even remember the last time Merck (MRK) got something approved or did not report poor results from a clinical tr...</description>
 <pubDate>Tue, 29 Jul 2008 09:26:22 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/etf-investor/1110296?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Background: The Clinical and Translational Science Awards Consortium (CTSA program)</title>
 <link>http://www.inveslogic.com/sectors/directory/biotech-blog/1109596?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Guest content from Christopher Starr:After years of confusion and neglect, translational research is now becoming institutionalized.Citing the barriers between the lab and clinic, along with the difficulties and complexities of conducting clinical re...</description>
 <pubDate>Mon, 28 Jul 2008 09:33:07 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biotech-blog/1109596?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Podcast interview with Dr. Michael Banks, co-founder of The Doctor   s Channel</title>
 <link>http://www.inveslogic.com/sectors/directory/health-business-blog/1108767?rsstype=tag&amp;tag=clinical-trial</link>
 <description>The Doctor   s Channel is a kind of YouTube for doctors. There   s a wide variety of content, everything from reports on clinical trial results to humorous videos to lifestyle tips. The videos are short and slick; I suggest you have a look.I spoke re...</description>
 <pubDate>Wed, 16 Jul 2008 21:33:26 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/health-business-blog/1108767?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>Sinovac Starts Phase II Trial of Pandemic Flu Vaccine</title>
 <link>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1104522?rsstype=tag&amp;tag=clinical-trial</link>
 <description>Sinovac Biotech Ltd. (AMEX: SVA) will begin enrolling volunteers in a Phase II clinical trial of its split viron pandemic influenza vaccine. The whole viron version of the vaccine has already completed its Phase II tests. The split viron candidate is...</description>
 <pubDate>Tue, 01 Jul 2008 02:28:59 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1104522?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
<item>
 <title>ImClone Systems Starts Solid Malignancies &amp; Lymphoma Trial Enrollment (IMCL)</title>
 <link>http://www.inveslogic.com/sectors/directory/biohealth-investor/1102859?rsstype=tag&amp;tag=clinical-trial</link>
 <description>ImClone Systems Inc. (NASDAQ: IMCL) has announced that its Phase 1 clinical trial of IMC-A12, itss fully human IgG1 anti-insulin-like growth factor-1 receptor monoclonal antibody plus the mTOR inhibitor temsirolimus, has opened for enrollment in pati...</description>
 <pubDate>Wed, 25 Jun 2008 07:27:04 -0400</pubDate>
 <guid>http://www.inveslogic.com/sectors/directory/biohealth-investor/1102859?rsstype=tag&amp;tag=clinical-trial</guid>
</item>
</channel>
</rss>
